| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL0877 | Name | MIR155HG | Aliases | BIC; MIRHG2; NCRNA00172 | |
| Species | Homo sapiens | Chromosome | 21 | Start site | 25561909 | |
| End site | 25575168 | Chain | plus | Exon NO. | 3 | |
| Assembly | Ensembl Release 89 | Class | lincRNA | NCBI accession | NR_001458 | |
| Ensembl | ENSG00000234883 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| chronic lymphocytic leukemia | N/A | N/A | N/A | Interaction | MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. | 21296997 | LncRNADisease | ||
| glioma | qPCR etc. | cell lines(U251, U87) | down-regulated | expression | MEG3 and ST7OT1 are up-regulated in both cell lines under apoptosis induced using both agents. The induction of GAS5 is only clearly detected during DOX-induced apoptosis, whereas the up-regulation of neat1 and MIR155HG is only found during RES-induced apoptosis in both cell lines. However, TUG1, BC200 and MIR155HG are down regulated when necrosis is induced using a high dose of DOX in both cell lines. | 25645334 | Lnc2Cancer | ||
| Interaction | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||||
| MYB | DNA-TF | regulation | MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. | 21296997 | LncRNADisease | ||||